Methods and reagents for the treatment of multiple sclerosis
US6890526B2 · kind B2 · utility
17Cited by
9References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 17, 2003 |
| Grant date | May 10, 2005 |
| Priority date | — |
| Expiry date | Apr 17, 2023 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/285
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention features methods and reagents for the diagnosis, monitoring, and treatment of multiple sclerosis. The invention is based in part on the discovery that Chlamydia is present in patients with multiple sclerosis, and that anti-chlamydial agents improve or sustain neurological function in these patients.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.